Opportunity Information: Apply for RFA HL 09 008
Apply for RFA HL 09 008
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Exploratory Studies in the Neurobiology of Pain in Sickle Cell Disease (R01)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.839 Blood Diseases and Resources Research 93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders.
- This funding opportunity was created on Nov 13, 2008 and posted on Nov 13, 2008.
- Applicants must submit their applications by Feb 3, 2009. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $1,200,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $300,000.00 in funding.
- The number of recipients for this funding is limited to 4 candidate(s).
- Eligible applicants include: County governments Small businesses Public housing authorities/Indian housing authorities Public and State controlled institutions of higher education Private institutions of higher education Native American tribal governments (Federally recognized) Others (see text field entitled Additional Information on Eligibility for clarification) State governments Special district governments Independent school districts Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Native American tribal organizations (other than Federally recognized tribal governments) City or township governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Non domestic (non U.S.) Entities (Foreign Organizations) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The grant opportunity titled "Exploratory Studies in the Neurobiology of Pain in Sickle Cell Disease (R01)" (Funding Opportunity Number RFA-HL-09-008) is an NIH discretionary funding announcement led by the National Heart, Lung, and Blood Institute (NHLBI) in partnership with the National Institute of Neurological Disorders and Stroke (NINDS). Its main goal is to support basic and translational research that digs into how pain works in sickle cell disease from a neurobiological perspective. In practical terms, the FOA is looking for projects that can clarify the nervous system mechanisms that drive sickle cell pain, including how pain is generated, amplified, sustained, and potentially transitioned into chronic states. A strong emphasis is placed on multidisciplinary approaches, meaning proposals that bring together expertise across fields such as hematology, neuroscience, pain biology, clinical research, imaging, genetics, behavioral science, or bioengineering are especially encouraged.
This opportunity uses the NIH Research Project Grant (R01) mechanism, which is designed for well-developed, hypothesis-driven research projects that can produce substantial new knowledge. Because the focus is exploratory studies in neurobiology, the intent is to stimulate innovative work that can open up new lines of investigation into sickle cell pain, including research that bridges laboratory findings with clinical observations. The announcement frames the work as spanning both basic science and translational pathways, which generally implies that strong applications could involve mechanistic animal or cellular studies, human experimental pain studies, biomarker development, neuroimaging approaches, or other methods that directly inform how pain is understood and ultimately treated in people with sickle cell disease.
In terms of funding, the FOA states that NHLBI intended to commit up to $6.0 million in total costs over four years and NINDS up to $1.4 million in total costs over four years, contingent on available appropriations. For fiscal year 2009 specifically, the institutes anticipated awarding about $1.85 million total to support four projects in response to this announcement. The posted summary also lists an estimated total funding amount of $1,200,000 and an award ceiling of $300,000, which signals that individual awards were expected to stay within a defined cap (as reflected in that listing), even though overall institute commitments across four years were higher when aggregated across awards and years. As with most NIH opportunities, final awards were explicitly contingent on both the availability of funds and the receipt of enough highly meritorious applications to justify making awards.
The eligibility scope is broad and includes many types of applicant organizations. Eligible applicants include public and private institutions of higher education, nonprofit organizations (including both 501(c)(3) and non-501(c)(3) entities), for-profit organizations (including but not limited to small businesses), and a wide range of governmental entities such as state, county, city/township governments, special district governments, independent school districts, public housing authorities, and tribal governments and tribal organizations. The FOA also notes additional eligible applicant categories such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, tribally controlled colleges and universities (TCCUs), Alaska Native and Native Hawaiian-serving institutions, faith-based or community-based organizations, regional organizations, U.S. territories or possessions, and even non-U.S. entities (foreign organizations). There is no cost sharing or matching requirement, meaning applicants were not required to contribute non-federal funds as a condition of the award.
Administratively, the opportunity was posted on November 13, 2008, with a closing date of February 3, 2009, and it was archived on March 6, 2009. It falls under the health funding activity category and is associated with CFDA numbers 93.839 (Blood Diseases and Resources Research) and 93.853 (Extramural Research Programs in the Neurosciences and Neurological Disorders), reflecting the joint hematology and neuroscience emphasis. The full announcement was hosted through the NIH grants guide, and NIH Office of Extramural Research webmaster contacts were provided for technical access issues.
Taken together, this FOA was essentially a targeted NIH call to push the field beyond descriptive accounts of sickle cell pain and into a more mechanistic, neurobiology-centered understanding, with the broader long-term implication that better mechanistic clarity can enable more precise and effective pain interventions. The institutes signaled that they valued collaborative, cross-disciplinary teams and projects that could connect nervous system biology to the real-world pain experience of individuals living with sickle cell disease.
Frequently Asked Questions (FAQs)
What is the title and funding opportunity number for this grant?
The opportunity is titled "Exploratory Studies in the Neurobiology of Pain in Sickle Cell Disease (R01)" and the Funding Opportunity Number is RFA-HL-09-008.
Which agencies or NIH institutes are leading this opportunity?
This is an NIH discretionary funding announcement led by the National Heart, Lung, and Blood Institute (NHLBI) in partnership with the National Institute of Neurological Disorders and Stroke (NINDS).
What is the overall purpose of this FOA?
The main goal is to support basic and translational research that examines how pain works in sickle cell disease from a neurobiological perspective, with an emphasis on clarifying nervous system mechanisms that drive sickle cell pain.
What kinds of scientific questions is the FOA trying to address?
The FOA is focused on studies that clarify how sickle cell pain is generated, amplified, sustained, and how it may transition into chronic pain states, specifically through nervous system and neurobiology-centered mechanisms.
What grant mechanism is used for this opportunity?
This opportunity uses the NIH Research Project Grant (R01) mechanism, which is intended for well-developed, hypothesis-driven research projects designed to produce substantial new knowledge.
Is the research expected to be basic, translational, or both?
The announcement frames the work as spanning both basic science and translational pathways. Strong applications may connect laboratory findings with clinical observations to improve understanding of pain in people living with sickle cell disease.
Does this FOA encourage multidisciplinary research teams?
Yes. A strong emphasis is placed on multidisciplinary approaches, and proposals that bring together expertise across fields are especially encouraged.
What disciplines are specifically mentioned as relevant?
The FOA explicitly highlights multidisciplinary work spanning areas such as hematology, neuroscience, pain biology, clinical research, imaging, genetics, behavioral science, and bioengineering.
What types of approaches or methods are implied as a fit for this FOA?
The description implies that projects could include mechanistic animal or cellular studies, human experimental pain studies, biomarker development, neuroimaging approaches, or other methods that directly inform how sickle cell pain is understood and ultimately treated.
How much funding did the institutes intend to commit overall?
The FOA states that NHLBI intended to commit up to $6.0 million in total costs over four years and NINDS up to $1.4 million in total costs over four years, contingent on available appropriations.
How many awards were anticipated for fiscal year 2009?
For fiscal year 2009, the institutes anticipated awarding about $1.85 million total to support four projects in response to this announcement.
Is there an award cap mentioned in the summary listing?
Yes. The posted summary lists an estimated total funding amount of $1,200,000 and an award ceiling of $300,000, signaling that individual awards were expected to stay within a defined cap as reflected in that listing.
How should applicants interpret the difference between the institute-wide commitments and the per-award ceiling shown in the summary?
The opportunity notes higher institute commitments when aggregated across awards and years (across four years), while the summary listing indicates an award ceiling for individual awards. In other words, overall totals reflect the combined portfolio across multiple projects and years, while the ceiling reflects the expected upper limit per award in that listing.
Are awards guaranteed if an application is submitted?
No. As with most NIH opportunities, awards were contingent on the availability of funds and on receiving a sufficient number of highly meritorious applications to justify making awards.
What types of organizations are eligible to apply?
Eligibility is broad and includes public and private institutions of higher education, nonprofit organizations (including 501(c)(3) and non-501(c)(3)), for-profit organizations (including but not limited to small businesses), and many governmental entities.
Which government entity types are listed as eligible applicants?
The FOA lists a wide range of eligible government applicants, including state governments, county governments, city or township governments, special district governments, independent school districts, public housing authorities, and tribal governments and tribal organizations.
Are minority-serving institutions and community-based organizations included in eligibility?
Yes. The FOA notes additional eligible categories such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, tribally controlled colleges and universities (TCCUs), Alaska Native and Native Hawaiian-serving institutions, faith-based or community-based organizations, and regional organizations.
Are U.S. territories or possessions eligible?
Yes. The FOA includes U.S. territories or possessions among the eligible applicant categories.
Are non-U.S. (foreign) organizations eligible to apply?
Yes. The eligibility section includes non-U.S. entities (foreign organizations).
Is cost sharing or matching required?
No. The FOA states there is no cost sharing or matching requirement.
When was this opportunity posted, and what were the close and archive dates?
The opportunity was posted on November 13, 2008. The closing date was February 3, 2009, and it was archived on March 6, 2009.
What is the funding activity category for this opportunity?
It falls under the health funding activity category.
Which CFDA numbers are associated with this FOA?
The opportunity is associated with CFDA 93.839 (Blood Diseases and Resources Research) and 93.853 (Extramural Research Programs in the Neurosciences and Neurological Disorders).
What does the FOA suggest about the longer-term impact of this research area?
The FOA positions the work as a way to push the field beyond descriptive accounts of sickle cell pain toward mechanistic, neurobiology-centered understanding, with the long-term implication that better mechanistic clarity can enable more precise and effective pain interventions.
Does the FOA explicitly value collaboration and cross-disciplinary teams?
Yes. The institutes signaled that they valued collaborative, cross-disciplinary teams and projects that connect nervous system biology to the real-world pain experience of individuals living with sickle cell disease.
Where was the full announcement hosted, and who was listed for technical access issues?
The full announcement was hosted through the NIH grants guide, and NIH Office of Extramural Research webmaster contacts were provided for technical access issues.
Browse more opportunities from the same category: Health
Next opportunity: Education Programs of Excellence in Scientifically Validated Behavioral Treatment (R25)
Previous opportunity: Collaborative Research in Integrative Cancer Biology and the Tumor Microenvironment (U01)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA HL 09 008
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA HL 09 008) also looked into and applied for these:
| Funding Opportunity |
|---|
| SSA Work Incentives Planning and Assistance Projects Apply for SSA OAG 09 1 Funding Number: SSA OAG 09 1 Agency: ODISP OESP Category: Health Funding Amount: $150,000 |
| National Institutes of Health Rapid Access to Interventional Development (NIH RAID) Program (X01) Apply for PAR 09 027 Funding Number: PAR 09 027 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Informing Systems Biology through Genetic VariationThe Genes, Environment and Health Initiative (R21) Apply for RFA MH 09 120 Funding Number: RFA MH 09 120 Agency: National Institutes of Health Category: Health Funding Amount: $400,000 |
| CAM Approaches in the Management of HIV Disease and Its Complications (R01) Apply for RFA AT 09 001 Funding Number: RFA AT 09 001 Agency: National Institutes of Health Category: Health Funding Amount: $400,000 |
| Service Expansion in Comprehensive Pharmacy Services (SEXPCPS) Apply for HRSA 09 156 Funding Number: HRSA 09 156 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Service Expansion in Mental Health/Substance Abuse (SEXPMHSA) Apply for HRSA 09 155 Funding Number: HRSA 09 155 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Exploratory Studies of Induced Pluripotent Stem (iPS) Cells from Healthy and Mental Health Patient Populations (R21/R33) Apply for RFA MH 09 130 Funding Number: RFA MH 09 130 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Service Expansion in Oral Health (SEXPOH) Apply for HRSA 09 154 Funding Number: HRSA 09 154 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Identifying Neighborhood Level Protective and Promotive Factors for Youth Violence (U01) Apply for RFA CE 09 008 Funding Number: RFA CE 09 008 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $350,000 |
| Service Area Competitions Apply for HRSA 09 210 Funding Number: HRSA 09 210 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Part C EIS CATEGORICAL GRANT PROGRAM TO PROVIDE OUTPATIENT EARLY INTERVENTION SERVICES WITH RESPECT TO HIV DISEASE Apply for HRSA 09 100 Funding Number: HRSA 09 100 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| NINDS Institutional Center Core Grants to Support Neuroscience Research (P30) Apply for PAR 08 116 Funding Number: PAR 08 116 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Capacity Building to Develop Standard Electronic Client Information Data Systems Parts C D Apply for HRSA 09 135 Funding Number: HRSA 09 135 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Adaptations of Evidence Based Parenting Programs to Engage Fathers in Child Maltreatment Prevention (U01) Apply for RFA CE 09 002 Funding Number: RFA CE 09 002 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $200,000 |
| Preventing Sexual Violence Perpetration Targeting Modifiable Risk Factors (U01) Apply for RFA CE 09 003 Funding Number: RFA CE 09 003 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $400,000 |
| Youth Violence Prevention through Economic, Environmental, and Policy Change (U01) Apply for RFA CE 09 009 Funding Number: RFA CE 09 009 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $500,000 |
| Integrated Preclinical/Clinical Program for HIV Topical Microbicides (IPCP HTM) (U19) Apply for RFA AI 08 057 Funding Number: RFA AI 08 057 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| MCH Research Network Programs Apply for HRSA 09 172 Funding Number: HRSA 09 172 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Rapid Response to Requests for Data Analysis Apply for HRSA 09 164 Funding Number: HRSA 09 164 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Rural Access to Emergency Devices Apply for HRSA 09 169 Funding Number: HRSA 09 169 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants

Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA HL 09 008", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
